Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation

Joseph W. Kim, Dana B. Cardin, Ulka N. Vaishampayan, Shumei Kato, Steven R. Grossman, Peter M. Glazer, Yu Shyr, S. Percy Ivy, Patricia M. LoRusso

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation'. Together they form a unique fingerprint.

Medicine & Life Sciences